Preview

Войти

Регистрация нового пользователя Забыли Ваш пароль?

Пульмонология

Расширенный поиск

Руководство Европейского респираторного общества по диагностике и лечению лимфангиолейомиоматоза

https://doi.org/10.18093/0869-0189-2010-6-9-23

Полный текст:

PDF (Rus)

Аннотация

Источник: Johnson S.R., Cordier J.F., Lazor R. et al. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur. Respir. J. 2010; 35: 14-26. В 2010 г. в Европейском респираторном журнале бы� ло опубликовано Руководство по диагностике и лече� нию лимфангиолейомиоматоза (ЛАМ). Это Руко� водство было подготовлено группой экспертов по инициативе Европейского респираторного общества (ЕРО).

Список литературы

1. Johnson S. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms. Thorax 1999; 54: 254-264

2. Franz D.N., Brody A., Meyer C. et al. Mutational and radi� ographic analysis of pulmonary disease consistent with lym� phangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am. J. Respir. Crit. Care Med. 2001; 164: 661-668

3. Urban T., Lazor R., Lacronique J. et al. Pulmonary lym� phangioleiomyomatosis. A study of 69 patients. Groupe d’Etudes et de Recherche sur les Maladies ‘‘Orphelines’’ Pulmonaires (GERM’’O’’P). Medicine (Baltimore) 1999; 78: 321-337

4. Johnson S.R., Tattersfield A.E. Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment. Am. J. Respir. Crit. Care Med. 1999; 160: 628-633

5. Aubry M.C., Myers J.L., Ryu J.H. et al. Pulmonary lym� phangioleiomyomatosis in a man. Am. J. Respir. Crit. Care Med. 2000; 162: 749-752

6. Schiavina M., Di Scioscio V., Contini P. et al. Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex. Am. J. Respir. Crit. Care Med. 2007; 176: 96-98

7. Avila N.A., Kelly J.A., Chu S.C. et al. Lymphangioleio� myomatosis: abdominopelvic CT and US findings. Radio� logy 2000; 216: 147-153

8. Chu S.C., Horiba K., Usuki J. et al. Comprehensive evalua� tion of 35 patients with lymphangioleiomyomatosis. Chest 1999; 115: 1041-1052

9. Moss J., DeCastro R., Patronas N.J. et al. Meningiomas in lymphangioleiomyomatosis. J. A. M. A. 2001; 286: 1879-1881

10. Johnson S.R., Tattersfield A.E. Clinical experience of lym� phangioleiomyomatosis in the UK. Thorax 2000; 55: 1052-1057

11. Ryu J.H., Doerr C.H., Fisher S.D. et al. Chylothorax in lym� phangioleiomyomatosis. Chest 2003; 123: 623-627

12. Goncharova E.A., Goncharov D.A., Eszterhas A. et al. Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor sup� pressor gene in pulmonary lymphangioleiomyomatosis (LAM). J. Biol. Chem. 2002; 277: 30958-30967

13. Kenerson H., Folpe A.L., Takayama T.K. et al. Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms. Hum. Pathol. 2007; 38: 1361-1371

14. Bissler J.J., McCormack F.X., Young L.R. et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphan� gioleiomyomatosis. N. Engl. J. Med. 2008; 358: 140-151

15. Davies D.M., Johnson S.R., Tattersfield A.E. et al. Sirolimus therapy in tuberous sclerosis or sporadic lymphangi� oleiomyomatosis. N. Engl. J. Med. 2008; 358: 200-203

16. McCrory D.C., Lewis S.Z. Methodology and grading for pul� monary hypertension evidence review and guideline devel� opment. Chest 2004; 126 (Suppl. 1): 11S-13S

17. Baumann M.H., Strange C., Heffner J.E. et al. Management of spontaneous pneumothorax: An American College of Chest Physicians Delphi Consensus Statement. Chest 2001; 119: 590-602

18. Ryu J.H., Moss J., Beck G.J. et al. The NHLBI lymphangi� oleiomyomatosis registry: characteristics of 230 patients at enrollment. Am. J. Respir. Crit. Care Med. 2006; 173: 105-111

19. Johnson S.R., Whale C.I., Hubbard R.B. et al. Survival and disease progression in UK patients with lymphangioleiomy� omatosis. Thorax 2004; 59: 800-803

20. Kitaichi M., Nishimura K., Itoh H. et al. Pulmonary lym� phangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am. J. Respir. Crit. Care Med. 1995; 151: 527-533

21. TaveiraDaSilva A.M., Stylianou M.P., Hedin C.J. et al. Decline in lung function in patients with lymphangi� oleiomyomatosis treated with or without progesterone. Chest 2004; 126: 1867-1874

22. Carrington C.B., Cugell D.W., Gaensler E.A. et al. Lymphangioleiomyomatosis. Physiologic�pathologic�radi� ologic correlations. Am. Rev. Respir. Dis. 1977; 116: 977-995

23. Matsui K., Beasley M.B., Nelson W.K. et al. Prognostic sig� nificance of pulmonary lymphangioleiomyomatosis histo� logic score. Am. J. Surg. Pathol. 2001; 25: 479-484

24. Corrin B., Liebow A., Friedman P. Pulmonary lymphan� giomyomatosis. A review. Am. J. Pathol. 1975; 79: 348-382

25. Bonetti F., Chiodera P.L., Pea M. et al. Transbronchial biop� sy in lymphangiomyomatosis of the lung. HMB45 for diag� nosis. Am. J. Surg. Pathol. 1993; 17: 1092-1102

26. Matsui K., Takeda K., Yu Z.X. et al. Downregulation of estro� gen and progesterone receptors in the abnormal smooth mus� cle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study. Am. J. Respir. Crit. Care Med. 2000; 161: 1002-1009

27. Glassberg M.K., Elliot S.J., Fritz J. et al. Activation of the estrogen receptor contributes to the progression of pul� monary lymphangioleiomyomatosis via MMP�induced cell invasiveness. J. Clin. Endocrinol. 2008; 93: 1625-1633

28. Zompatori M., Poletti V., Battista G. et al. Diffuse cystic lung disease in the adult patient. Radiol. Med. (Torino) 2000; 99: 12-21

29. Steagall W.K., Glasgow C.G., Hathaway O.M. et al. Genetic and morphologic determinants of pneumothorax in lym� phangioleiomyomatosis. Am. J. Physiol. Lung Cell Mol. Physiol. 2007; 293: L800-L808

30. Lenoir S., Grenier P., Brauner M.W. et al. Pulmonary lym� phangiomyomatosis and tuberous sclerosis: comparison of radiographic and thin�section CT findings. Radiology 1990; 175: 329-334

31. Muller N.L., Chiles C., Kullnig P. Pulmonary lymphan� giomyomatosis: correlation of CT with radiographic and functional findings. Radiology 1990; 175: 335-339

32. Abbott G.F., RosadodeChristenson M.L., Frazier A.A. et al. From the archives of the AFIP: lymphangioleiomyomatosis: radiologicpathologic correlation. Radiographics 2005; 25: 803-828

33. Helenon O., Merran S., Paraf F. et al. Unusual fat�contain� ing tumors of the kidney: a diagnostic dilemma. Radiographics 1997; 17: 129-144

34. Roach E.S., Sparagana S.P. Diagnosis of tuberous sclerosis complex. J. Child Neurol. 2004; 19: 643-649

35. TaveiraDaSilva A.M., Hedin C., Stylianou M.P. et al. Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis. Am. J. Respir. Crit. Care Med. 2001; 164: 1072-1076

36. Taylor J.R., Ryu J., Colby T.V. et al. Lymphangio� leiomyomatosis. Clinical course in 32 patients. N. Engl. J. Med. 1990; 323: 1254-1260

37. Boehler A., Speich R., Russi E.W. et al. Lung transplantation for lymphangioleiomyomatosis. N. Engl. J. Med. 1996; 335: 1275-1280

38. TaveiraDaSilva A.M., Stylianou M.P., Hedin C.J. et al. Maximal oxygen uptake and severity of disease in lymphan� gioleiomyomatosis. Am. J. Respir. Crit. Care Med. 2003; 168: 1427-1431

39. Costello L.C., Hartman T.E., Ryu J.H. High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clin. Proc. 2000; 75: 591-594

40. Moss J., Avila N.A., Barnes P.M. et al. Prevalence and clini� cal characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. Am. J. Respir. Crit. Care Med. 2001; 164: 669-671

41. Castro M., Shepherd C.W., Gomez M.R. et al. Pulmonary tuberous sclerosis. Chest 1995; 107: 189-195

42. Kim N.R., Chung M.P., Park C.K. et al. Pulmonary lym� phangioleiomyomatosis and multiple hepatic angiomy� olipomas in a man. Pathol. Int. 2003; 53: 231-235

43. Casper K.A., Donnelly L.F., Chen B. et al. Tuberous sclerosis complex: renal imaging findings. Radiology 2002; 225: 451-456

44. Ewalt D.H., Sheffield E., Sparagana S.P. et al. Renal lesion growth in children with tuberous sclerosis complex. J. Urol. (Baltimore) 1998; 160: 141-145

45. Weiner D.M., Ewalt D.H., Roach E.S. et al. The tuberous sclerosis complex: a comprehensive review. J. Am. Coll. Surg. 1998; 187: 548-561

46. L’Hostis H., Deminiere C., Ferriere J.M. et al. Renal angiomyolipoma: a clinicopathologic, immunohistochemi� cal, and follow�up study of 46 cases. Am. J. Surg. Pathol. 1999; 23: 1011-1020

47. Nelson C.P., Sanda M.G. Contemporary diagnosis and management of renal angiomyolipoma. J. Urol. (Baltimore) 2002; 168: 1315-1325

48. Steiner M.S., Goldman S.M., Fishman E.K. et al. The natu� ral history of renal angiomyolipoma. J. Urol. (Baltimore) 1993; 150: 1782-1786

49. Kennelly M.J., Grossman H.B., Cho K.J. Outcome analysis of 42 cases of renal angiomyolipoma. J. Urol. (Baltimore) 1994; 152: 1988-1991

50. Dickinson M., Ruckle H., Beaghler M. et al. Renal angiomy� olipoma: optimal treatment based on size and symptoms. Clin. Nephrol. 1998; 49: 281-286

51. Lazor R., Valeyre D., Lacronique J. et al. Low initial KCO predicts rapid FEV1 decline in pulmonary lymphangi� oleiomyomatosis. Respir. Med. 2004; 98: 536-541

52. Cohen M.M., PollockBarZiv S., Johnson S.R. Emerging clinical picture of lymphangioleiomyomatosis. Thorax 2005; 60: 875-879

53. Almoosa K.F., Ryu J.H., Mendez J. et al. Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications. Chest 2006; 129: 1274-1281

54. Fujimoto M., Ohara N., Sasaki H. et al. Pregnancy compli� cated with pulmonary lymphangioleiomyomatosis: case report. Clin. Exp. Obstetr. Gynecol. 2005; 32: 199-200

55. Brunelli A., Catalini G., Fianchini A. Pregnancy exacerbating unsuspected mediastinal lymphangioleiomyomatosis and chylothorax. Int. J. Gynaecol. Obstetr. 1996; 52: 289-290

56. McLoughlin L., Thomas G., Hasan K. Pregnancy and lym� phangioleiomyomatosis: anaesthetic management. Int. J. Obstetr. Anesth. 2003; 12: 40-44

57. Yockey C.C., Riepe R.E., Ryan K. Pulmonary lymphangi� oleiomyomatosis complicated by pregnancy. Kans. Med. 1986; 87: 277-278, 293

58. Warren S.E., Lee D., Martin V. et al. Pulmonary lymphan� giomyomatosis causing bilateral pneumothorax during pregnancy. Ann. Thorac. Surg. 1000; 55: 998-1000

59. Cohen M.M., Freyer A.M., Johnson S.R. Pregnancy experi� ences among women with lymphangioleiomyomatosis. Respir. Med. 2009; 103: 766-772

60. Raft J., Lalot J.M., Meistelman C. et al. Renal angiomy� olipoma rupture during pregnancy. Gynecol. Obstetr. Fertil 2006; 34: 917-919

61. Storm D.W., Mowad J.J. Conservative management of a bleeding renal angiomyolipoma in pregnancy. Obstetr. and Gynecol. 2006; 107: 490-492

62. Morales J.P., Georganas M., Khan M.S. et al. Embolization of a bleeding renal angiomyolipoma in pregnancy: case report and review. Cardiovasc. Intervent. Radiol. 2005; 28: 265-268

63. Mascarenhas R., McLaughlin P. Haemorrhage from angiomyolipoma of kidney during pregnancy - a diagnostic dilemma. Ir. Med. J. 2001; 94: 83-84

64. Yano S. Exacerbation of pulmonary lymphangioleiomy� omatosis by exogenous oestrogen used for infertility treat� ment. Thorax 2002; 57: 1085-1086

65. Shen A., Iseman M.D., Waldron J.A. et al. Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous estro� gens. Chest 1987; 91: 782-785

66. Wilson A.M., Slack H.L., Soosay S.A. et al. Lymphangioleio� myomatosis. A series of three case reports illustrating the link with high oestrogen states. Scott. Med. J. 2001; 46: 150-152

67. Oberstein E.M., Fleming L.E., GomezMarin O. et al. Pulmonary lymphangioleiomyomatosis (LAM): examining oral contraceptive pills and the onset of disease. J. Women’s Hlth 2003; 12: 81-85

68. PollockBarZiv S., Cohen M.M., Downey G.P. et al. Air trav� el in women with lymphangioleiomyomatosis. Thorax 2007; 62: 176-180

69. Rehabilitation BTSSoCs�coP. BTS statement on pul� monary rehabilitation. Thorax 2001; 56: 827-834

70. Managing stable COPD. Thorax 2004; 59: (Suppl. 1), i39-i130

71. TaveiraDaSilva A.M., Stylianou M.P., Hedin C.J. et al. Bone mineral density in lymphangioleiomyomatosis. Am. J. Respir. Crit. Care Med. 2005; 171: 61-67

72. Adamson D., Heinrichs W.L., Raybin D.M. et al. Successful treatment of pulmonary lymphangiomyomatosis with oophorectomy and progesterone. Am. Rev. Respir. Dis. 1985; 132: 916-921

73. Anker N., Francis D., Viskum K. 2 cases of lymphangi� oleiomyomatosis treated by hormonal manipulation. Ugeskr. Laeg. 1993; 155: 2354-2356

74. Banner A.S., Carrington C.B., Emory W.B. et al. Efficacy of oophorectomy in lymphangioleiomyomatosis and benign metastasizing leiomyoma. N. Engl. J. Med. 1981; 305: 204-209

75. Itoi K., Kuwabara M., Okubo K. et al. A case of pulmonary lymphangiomyomatosis treated with bilateral oophorecto� my and methyl�progesterone�acetate. Nihon Kyobu Shikkan Gakkai Zasshi 1993; 31: 1146-1150

76. Brock E.T., Votto J.J. Lymphangioleiomyomatosis: treat� ment with hormonal manipulation. N. Y. St. J. Med. 1986; 86: 533-536

77. Klein M., Krieger O., Ruckser R. et al. Treatment of lym� phangioleiomyomatosis by ovariectomy, interferon alpha 2b and tamoxifen - a case report. Arch. Gynecol. Obstetr. 1992; 252: 99-102

78. Svendsen T.L., Viskum K., Hansborg N. et al. Pulmonary lymphangioleiomyomatosis: a case of progesterone receptor positive lymphangioleiomyomatosis treated with medrox� yprogesterone, oophorectomy and tamoxifen. Br. J. Dis. Chest 1984; 78: 264-271

79. Tomasian A., Greenberg M.S., Rumerman H. Tamoxifen for lymphangioleiomyomatosis. N. Engl. J. Med. 1982; 306: 745-746

80. de la Fuente J., Paramo C., Roman F. et al. Lymphangio� leiomyomatosis: unsuccessful treatment with luteinizing� hormone�releasing hormone analogues. Eur. J. Med. 1993; 2: 377-378

81. Desurmont S., Bauters C., Copin M.C. et al. Treatment of pulmonary lymphangioleiomyomatosis using a GnRH ago� nist. Rev. Mal. Respir. 1996; 13: 300-304

82. Rossi G.A., Balbi B., Oddera S. et al. Response to treatment with an analog of the luteinizing�hormone�releasing hor� mone in a patient with pulmonary lymphangioleiomy� omatosis. Am. Rev. Respir. Dis. 1991; 143: 174-176

83. Harari S., Cassandro R., Chiodini J. et al. Effect of a gonadotrophin�releasing hormone analogue on lung func� tion in lymphangioleiomyomatosis. Chest 2008; 133: 448-454

84. Detterbeck F.C., Egan T.M., Mill M.R. Lung transplantation after previous thoracic surgical procedures. Ann. Thorac. Surg. 1995; 60: 139-143

85. Pechet T.T., Meyers B.F., Guthrie T.J. et al. Lung transplan� tation for lymphangioleiomyomatosis. J. Heart Lung Transplant. 2004; 23: 301-308

86. Morimoto N., Hirasaki S., Kamei T. et al. Pulmonary lym� phangiomyomatosis (LAM) developing chylothorax. Intern. Med. 2000; 39: 738-741

87. Avila N.A., Dwyer A.J., Rabel A. et al. CT of pleural abnor� malities in lymphangioleiomyomatosis and comparison of pleural findings after different types of pleurodesis. Am. J. Roentgenol. 2006; 186: 1007-1012

88. Druelle S., Aubry P., LeviValensi P. Pulmonary lymphan� giomyomatosis: a 3�year follow�up of medroxyprogesterone acetate therapy. Apropos of a case. Rev. Pneumol. Clin. 1995; 51: 284-287

89. Zanella A., Toppan P., Nitti D. et al. Pulmonary lymphangi� oleiomyomatosis: a case report in postmenopausal woman treated with pleurodesis and progesterone (medroxyproges� terone acetate). Tumori 1996; 82: 96-98

90. Woґjcik P., Otto T., Jagieііo R. et al. Use of pleuro�peri� toneal shunt in the treatment of chronic chylothorax. Pneumonol. Alergol. Pol. 1998; 66: 473-479

91. Calvo E., Amarillas L., Mateos M.A. et al. Lymphangioleio� myomatosis, chylous ascites, and diet. Dig. Dis. Sci. 1996; 41: 591-593

92. Hamlin J.A., Smith D.C., Taylor F.C. et al. Renal angiomy� olipomas: long�term follow�up of embolization for acute hemorrhage. Can. Assoc. Radiol. J. 1997; 48: 191-198

93. Williams J.M., Racadio J.M., Johnson N.D. et al. Embolization of renal angiomyolipomata in patients with tuberous sclerosis complex. Am. J. Kidney Dis. 2006; 47: 95-102

94. Igarashi A., Masuyama T., Watanabe K. et al. Long�term result of the transcatheter arterial embolization for ruptured renal angiomyolipoma. Nippon Hinyokika Gakkai Zasshi 2002; 93: 702-706

95. Bender B., Yunis E. The pathology of tuberous sclerosis. Pathol. Annu. 1982; 17: 339-382

96. Yamakado K., Tanaka N., Nakagawa T. et al. Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture. Radiology 2002; 225: 78-82

97. Trulock E.P. Lung transplantation: special considerations and outcome in LAM. In: Moss J., ed. LAM and other dis� eases characterised by smooth muscle proliferation. New York: Marcel Dekker; 1999. 65-78

98. Pigula F.A., Griffith B.P., Zenati M.A. et al. Lung trans� plantation for respiratory failure resulting from systemic disease. Ann. Thorac. Surg. 1997; 64: 1630-1634

99. Kpodonu J., Massad M.G., Chaer R.A. et al. The US experi� ence with lung transplantation for pulmonary lymphangi� oleiomyomatosis. J. Heart Lung Transplant. 2005; 24: 1247-1253

100. Boehler A. Lung transplantation for cystic lung diseases: lymphangioleiomyomatosis, histiocytosis x, and sarcoido� sis. Semin. Respir. Crit. Care Med. 2001; 22: 509-516

101. Benden C., Rea F., Behr J. et al. Lung transplantation for lymphangioleiomyomatosis: the European experience. J. Heart Lung Transplant. 2009; 28: 1-7

102. ReynaudGaubert M., Mornex J.F., Mal H. et al. Lung trans� plantation for lymphangioleiomyomatosis: the French experience. Transplantation 2008; 86: 515-520

103. Collins J., Muller N.L., Kazerooni E.A. et al. Lung trans� plantation for lymphangioleiomyomatosis: role of imaging in the assessment of complications related to the underlying disease. Radiology 1999; 210: 325-332

104. Nine J.S., Yousem S.A., Paradis I.L. et al. Lymphangio� leiomyomatosis: recurrence after lung transplantation. J. Heart Lung Transplant. 1994; 13: 714-719

105. Bittmann I., Rolf B., Amann G. et al. Recurrence of lym� phangioleiomyomatosis after single lung transplantation: New insights into pathogenesis. Hum. Pathol. 2003; 34: 95-98

106. Karbowniczek M., Astrinidis A., Balsara B.R. et al. Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. Am. J. Respir. Crit. Care Med. 2003; 167: 976-982

107. Benden C., Boehler A., Faro A. Pediatric lung transplanta� tion: Literature review. Pediatr. Transplant. 2008; 12: 266-273


Для цитирования:

Джонсон С.Р., Кордье Д.Ф., Лазор К..., Коттен В..., Костабель У..., Харари С..., Рено�Габер М..., Болер А..., Броне М..., Поппер Х..., Кингсвуд К... Руководство Европейского респираторного общества по диагностике и лечению лимфангиолейомиоматоза. Пульмонология. 2010;(6):9-23. https://doi.org/10.18093/0869-0189-2010-6-9-23

Просмотров: 29


ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)
Россия, 105077, Москва,
улица 11-я Парковая, дом 32, корпус 4, этаж 6, офис 657
Тел.: 8-925-744-72-98
E-mail: pulmo@pulmonology.ru
создано и поддерживается NEICON
(лаборатория Elpub)
powered by PKP OJS